SVRA Savara
- 4.460
- -0.120-2.62%
- 4.450
- -0.010-0.22%
Savara News
Savara Inc.'s (NASDAQ:SVRA) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 14% Over Last Week
Savara Shares Climb on $100 Million Share Offering
Express News | Savara Inc: Prices Offering of 26.2 Mln Shares at $3.81/Share
Express News | Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
Savara Is Maintained at Buy by Guggenheim
Guggenheim Maintains Buy on Savara, Raises Price Target to $10
Oppenheimer Adjusts Price Target on Savara to $15 From $11, Maintains Outperform Rating
Evercore Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $7
Evercore analyst Liisa Bayko maintains $Savara(SVRA.US)$ with a buy rating, and maintains the target price at $7.According to TipRanks data, the analyst has a success rate of 44.5% and a total average
Guggenheim Maintains Savara(SVRA.US) With Buy Rating, Raises Target Price to $10
Guggenheim analyst Vamil Divan maintains $Savara(SVRA.US)$ with a buy rating, and adjusts the target price from $7 to $10.According to TipRanks data, the analyst has a success rate of 54.0% and a tota
A Quick Look at Today's Ratings for Savara(SVRA.US), With a Forecast Between $7 to $15
On Jun 27, major Wall Street analysts update their ratings for $Savara(SVRA.US)$, with price targets ranging from $7 to $15.Jefferies analyst Andrew Tsai maintains with a buy rating, and maintains the
Express News | Savara Inc : Guggenheim Raises Target Price to $10 From $8
Savara Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Savara, Raises Price Target to $10
Express News | Savara, Inc. : H.c. Wainwright Raises Target Price to $10 From $6
Savara Down Nearly 11%, on Pace for Largest Percent Decrease Since March 2023 -- Data Talk
Savara Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains Outperform on Savara, Raises Price Target to $15
Savara Analyst Ratings
Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday?
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday
Analysis
Price Target
No Data
